Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
Part of paid clinical trials in San Diego, California.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT03803423
- Status
- Recruiting
Conditions
- End Stage Liver Disease
- End Stage Renal Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- The Donor App — OTHERThe Donor app is a web-based application that helps transplant candidates tell the candidate's story via social media in the hopes of identifying an appropriate living donor. Sample stories created using the Donor App can be found at www.thedonorapp.com.
Study Details
This study utilizes a web-based application to help patients on the organ transplant waitlist communicate patient's need for a living donor via social media and provide interested potential donors the opportunity to engage with the evaluation process.
Key Dates
- Start date
- Nov 27, 2017
- Status verified
- Nov 2025
- Primary completion
- Nov 27, 2026
- Completion
- Nov 27, 2026
Study Design
- Enrollment
- 1,000 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: The Donor AppSelect physicians and research staff from about 15 transplant hospitals will be given access to distribute the application to patients who the above people feel could benefit from the application. After obtaining informed consent, an approved member of the study team will enter the participant's name, contact info, and organ needed into the Donor App's secure management portal to send an email or text message with a unique and protected invitation link to the participant. Using this link the participant will be allowed to use the Donor App indefinitely.
Primary Outcome Measure
Potential donors identified [ Time Frame: Up to 5 years ]
Central Contacts
- Andrew Cameron, MD PhD4432870134
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Scripps Green Hospital | San Diego | California | 92037 | - |
| Yale University | New Haven | Connecticut | 06520 | - |
| Rush University Medical Center | Chicago | Illinois | 60612 | Sherri Loeb, BSN |
| Maine Medical Center | Portland | Maine | 04102 | - |
| The Johns Hopkins Hospital | Baltimore | Maryland | 21218 | Andrew Cameron, MD PhD (PRINCIPAL_INVESTIGATOR) |
| Washington University in St. Louis | St Louis | Missouri | 63110 | - |
Find similar trials in San Diego, CA
Related Studies
- Functional Assessment in Liver TransplantationRecruiting · University of California, San Francisco · Little Rock, Arkansas
- Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRDPHASE2 · Recruiting · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company · San Francisco, California
- Angiotensin 2 for AKI After OLTPHASE4 · Enrolling By Invitation · University of California, Los Angeles · Los Angeles, California
- CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney DiseasePHASE3 · Recruiting · Vanderbilt University Medical Center · Sacramento, California